Non-Oral Benzodiazepine Combination Feasible for Seizures in Patients With Gliomas
the ONA take:
It is feasible to treat seizures with a combination of non-oral benzodiazepines in the end-of-life phase of patients with gliomas, a new study published online ahead of print in the journal Supportive Care in Cancer has shown.
Because a rapid deterioration in neurological functioning may interfere with the oral intake of antiepileptic drugs (AEDs) for patients with gliomas who are at the end of life, researchers sought to assess the feasibility of non-oral AED treatment in an outpatient setting.
Researchers enrolled 25 patients with gliomas who had a history of epilepsy and were no longer deemed appropriate candidates for further antitumor therapy. Caregivers were to administer prophylactic treatment with buccal clonazepam as soon as swallowing difficulties developed. Acute seizures were treated with intranasal midazolam.
Results showed that seizure control was achieved in all patients and none of the patients needed to be admitted to the hospital due to recurrent seizures.
The combination of AEDs “seems to provide an important level of comfort among caregivers to be able to manage seizures at home,” the authors concluded.
It is feasible to treat seizures with a combination of non-oral benzodiazepines in the end-of-life phase of patients with gliomas.
Johan A. F. Koekkoek Affiliated withDepartment of Neurology, VU University Medical Center Department of Neurology, Medical Center Haaglanden Department of Neurology, Leiden University Medical Center Email author , Martin J. B.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|